Renvio Partners with Klinrisk to Pioneer Embedded AI Solutions in Kidney Care

Announcing the launch of Predictive AI as a new feature within Renvio's Dialysis Manager EMR

RANCHO SANTA MARGARITA, Calif., Sept. 15, 2025 /PRNewswire/ -- Renvio, the leading EMR platform for independent dialysis providers, today announced a strategic partnership with Klinrisk, a leader in predictive AI for chronic disease. This collaboration will power the next generation of AI-enabled tools for kidney care—starting with Hospitalization and Dialysis Adequacy Risk—natively integrated within Renvio's Dialysis Manager EMR at the point of care.

As kidney care continues to shift toward value-based models, Renvio and Klinrisk are charting a new path: delivering intelligent insights where and when care happens. Unlike legacy vendors or bolt-on solutions, Renvio's Predictive AI features enable clinicians to act on AI-driven recommendations without leaving their workflow—making predictive insights not only accessible but actionable.

"Klinrisk brings world-class AI capabilities, and Renvio brings the context," said Chris Sigala, CEO of Renvio. "This partnership is about more than prediction—it's about empowering clinicians to take the right action, at the right time, in the flow of care. That's the future of intelligent kidney care."

By embedding advanced risk stratification and recommended clinical workflows directly into the Renvio EMR, Renvio's Predictive AI solutions will support real-time clinical interventions, medication optimization, and care coordination for patients with end stage renal disease (ESRD). A key feature of the Predictive AI will be to always keep the nephrologist in the loop. Early pilots will target reduction of preventable hospitalizations—a key driver of cost and poor outcomes in kidney populations.

This announcement positions Renvio as the first EMR in kidney care to offer a fully embedded AI engine, tightly aligned with clinician workflows. It also underscores the company's broader vision to build the most intelligent operating system in kidney care.

"We're thrilled to partner with Renvio to put predictive intelligence directly in the hands of providers," said Dr. Navdeep Tangri, CEO of Klinrisk. "Together, we're making AI not just smart—but actionable at the point of care."

About Renvio
Renvio is the leading electronic medical record platform serving the independent dialysis and kidney care market. Purpose-built for kidney care, Renvio empowers clinicians and operators with the tools they need to thrive in value-based care—streamlining operations, improving outcomes, and delivering care that's both personal and data-driven.

About Klinrisk
Klinrisk is a healthcare AI company focused on improving outcomes for chronic disease patients through predictive analytics and machine learning. Its solutions help providers identify risk, drive early intervention, and optimize care delivery across complex populations.

SOURCE Renvio